Prevention, Diagnosis & Treatment

Prevention, Diagnosis & Treatment

Bayer’s brands treat and prevent conditions to improve quality of life.

Pharma News

June 19, 2019

Bayer's Stivarga® (regorafenib) becomes first compound used in clinical trial platform to investigate new therapies for brain cancer

Bayer announced today that the Stivarga® (regorafenib) arm of the platform trial GBM AGILE (Glioblastoma Adaptive Global Innovative Learning Environment) has opened enrollment for patients with...

Learn more
June 04, 2019

Bayer and Arvinas, Inc. to develop novel Proteolysis-Targeting Chimera candidates for humans and plants

Bayer today announced a collaboration with Arvinas, Inc. (Nasdaq: ARVN), a biopharmaceutical company based in New Haven, Connecticut. The new life science research partnership uniquely leverages...

Learn more
June 03, 2019

New data on Vitrakvi® (larotrectinib) in TRK fusion cancer patients with brain metastases or primary central nervous system (CNS) tumors

Bayer today announced results of a new analysis from clinical trials investigating Vitrakvi® (larotrectinib) in patients with TRK fusion cancer with primary central nervous system (CNS) tumors or...

Learn more